AU2711695A - Azaaliphatically bridged quinoxaline-2,3-diones - Google Patents
Azaaliphatically bridged quinoxaline-2,3-dionesInfo
- Publication number
- AU2711695A AU2711695A AU27116/95A AU2711695A AU2711695A AU 2711695 A AU2711695 A AU 2711695A AU 27116/95 A AU27116/95 A AU 27116/95A AU 2711695 A AU2711695 A AU 2711695A AU 2711695 A AU2711695 A AU 2711695A
- Authority
- AU
- Australia
- Prior art keywords
- azaaliphatically
- diones
- bridged quinoxaline
- quinoxaline
- bridged
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH236694 | 1994-07-27 | ||
CH2366/94 | 1994-07-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2711695A true AU2711695A (en) | 1996-02-08 |
Family
ID=4232111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27116/95A Abandoned AU2711695A (en) | 1994-07-27 | 1995-07-20 | Azaaliphatically bridged quinoxaline-2,3-diones |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0705834A1 (en) |
JP (1) | JPH0873465A (en) |
KR (1) | KR960004346A (en) |
CN (1) | CN1117493A (en) |
AU (1) | AU2711695A (en) |
BR (1) | BR9503458A (en) |
CA (1) | CA2154624A1 (en) |
FI (1) | FI953549A (en) |
HU (1) | HUT73438A (en) |
IL (1) | IL114729A0 (en) |
NO (1) | NO952959L (en) |
NZ (1) | NZ272639A (en) |
ZA (1) | ZA956209B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5704898A (en) * | 1996-12-16 | 1998-07-15 | Warner-Lambert Company | Tricyclic quinoxaline derivatives as neuroprotective agents |
AU9651198A (en) | 1997-11-11 | 1999-05-31 | Ono Pharmaceutical Co. Ltd. | Fused pyrazine compounds |
MX2012004769A (en) | 2009-10-26 | 2012-08-08 | Warner Chilcott Co Llc | Bisphosphonate compounds for treating bone metabolism disorders. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK715888D0 (en) * | 1988-12-22 | 1988-12-22 | Ferrosan As | QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE |
DK716188D0 (en) * | 1988-12-22 | 1988-12-22 | Ferrosan As | QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE |
HU210264B (en) * | 1989-06-09 | 1995-03-28 | Upjohn Co | Process for producing amines of condensed ring-systems containing nitrogen and pharmaceutical compositions containing them |
JPH05117276A (en) * | 1991-10-23 | 1993-05-14 | Sumitomo Pharmaceut Co Ltd | New tricyclic quinoxalinedione derivative |
WO1994000124A1 (en) * | 1992-06-22 | 1994-01-06 | Eckard Weber | Glycine receptor antagonists and the use thereof |
EP0664807B1 (en) * | 1992-10-13 | 1997-09-10 | Warner-Lambert Company | Quinoxalinedione derivatives as eaa antagonists |
US5631373A (en) * | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
-
1995
- 1995-07-18 EP EP95810470A patent/EP0705834A1/en not_active Withdrawn
- 1995-07-20 AU AU27116/95A patent/AU2711695A/en not_active Abandoned
- 1995-07-24 FI FI953549A patent/FI953549A/en not_active Application Discontinuation
- 1995-07-25 IL IL11472995A patent/IL114729A0/en unknown
- 1995-07-25 JP JP7189177A patent/JPH0873465A/en active Pending
- 1995-07-25 NZ NZ272639A patent/NZ272639A/en unknown
- 1995-07-25 CA CA002154624A patent/CA2154624A1/en not_active Abandoned
- 1995-07-26 KR KR1019950022224A patent/KR960004346A/en not_active Application Discontinuation
- 1995-07-26 NO NO952959A patent/NO952959L/en unknown
- 1995-07-26 CN CN95108718A patent/CN1117493A/en active Pending
- 1995-07-26 HU HU9502240A patent/HUT73438A/en unknown
- 1995-07-26 ZA ZA956209A patent/ZA956209B/en unknown
- 1995-07-26 BR BR9503458A patent/BR9503458A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ272639A (en) | 1997-05-26 |
CN1117493A (en) | 1996-02-28 |
KR960004346A (en) | 1996-02-23 |
ZA956209B (en) | 1996-01-29 |
NO952959L (en) | 1996-01-29 |
FI953549A0 (en) | 1995-07-24 |
JPH0873465A (en) | 1996-03-19 |
CA2154624A1 (en) | 1996-01-28 |
EP0705834A1 (en) | 1996-04-10 |
BR9503458A (en) | 1996-02-27 |
FI953549A (en) | 1996-01-28 |
NO952959D0 (en) | 1995-07-26 |
IL114729A0 (en) | 1995-11-27 |
HU9502240D0 (en) | 1995-09-28 |
HUT73438A (en) | 1996-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6720798A (en) | 2-arylcyclopentan-1,3-diones | |
AU2925195A (en) | 2-aryl cyclopentane-1,3-dione derivatives | |
AU2681895A (en) | 8-aryl-1,6-naphthyridin-5-ones | |
ZA9711092B (en) | Novel compounds. | |
AU4984497A (en) | Germicidal composition | |
AU9068498A (en) | 2-benzoyl-cyclohexane-1,3-dione as herbicides | |
AU2091897A (en) | 2-hetaroylcyclohexane-1,3-diones | |
AU6123196A (en) | N-aryl-1,2,4-triazolin-5-ones | |
AU9156198A (en) | 2-benzoyl-cyclohexane-1,3-diones | |
AU3028795A (en) | Oxa- or thia-aliphatically bridged quinoxaline-2,3-diones | |
AU1636297A (en) | Novel 2,3-benzodiazepine derivatives | |
AU4720397A (en) | Terpenylated diketopiperazines, (drimentines) | |
AU4218997A (en) | 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds | |
AU7570296A (en) | 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols | |
ZA988B (en) | 3-aminocarbonyl-/3-aminothiocarbonyl-substituted 2-benzoylcyclohexane-1,3-diones. | |
ZA9710860B (en) | Adhesives. | |
AU2711695A (en) | Azaaliphatically bridged quinoxaline-2,3-diones | |
AU2964899A (en) | 2,4-dioxo-5-arylidenimino-1,3-pyrimidines | |
AUPP003297A0 (en) | 4,5-diaryloxazole compounds | |
AU1513597A (en) | 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives | |
AU3150395A (en) | Retroviral protease inhibiting 1,2,4-triazacycloheptanes | |
AU6532696A (en) | Novel 6-substituted-5,8-dioxy-1,4-naphthoquinone derivatives | |
AU2137095A (en) | Heterocyclyl-1,3,4-thiadiazolyloxyacetamides | |
AU748974C (en) | Substituted 2-benzoyl-cyclohexane-1,3-diones | |
AU4723897A (en) | 1,4-benzoquinone derivatives |